RT Journal Article
SR Electronic
T1 1074 PK/RO modeling of WTX-124, a tumor-activated IL-2 prodrug, highlights the potential for a substantially improved therapeutic index compared to other IL-2 molecules
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1183
OP A1183
DO 10.1136/jitc-2023-SITC2023.1074
VO 11
IS Suppl 1
A1 Subramanian, Kulandayan K
A1 Chopra, Sameer
A1 Morris, Kristin
A1 Nirschl, Christopher J
A1 Domonkos, Celesztina
A1 Economides, Kyriakos
A1 Salmeron, Andres
A1 Seidel-Dugan, Cynthia
A1 Isaacs, Randi
A1 Hicklin, Daniel J
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1183.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.